Aliskiren/amlodipine/hydrochlorothiazide

Aliskiren/amlodipine/hydrochlorothiazide
Combination of
Aliskiren Renin inhibitor
Amlodipine Calcium channel blocker
Hydrochlorothiazide Diuretic
Clinical data
AHFS/Drugs.com Consumer Drug Information
License data
Pregnancy
category
  • US: D (Evidence of risk)
    Routes of
    administration    		 Oral
    ATC code
    Legal status
    Legal status
    Identifiers
    CAS Number
      (verify)

    The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs, trade name Amturnide) is an antihypertensive approved by the U.S. Food and Drug Administration (FDA) on December 21, 2010.[1]

    References

    1. ↑ Amturnide approval letter. U.S. Food and Drug Administration (FDA).


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.